FDA:アデュカヌマブを優先審査指定 :アルツハイマー病治療薬(動画):  FDA: Priority screening designation for Aducanumab: Alzheimer’s drug:  FDA:Aducanumab的优先筛查指定:阿尔茨海默氏病药物

Alzheimer, disease, Pharmaceutical

COVID-19:アクテムラ、重症に有効性示せず:海外第3相臨床試験(動画):  COVID-19:Actemra/Roche shows no efficacy in severe cases: Phase3 trial: COVID-19:罗氏Actemra在严重病例中未显示疗效:海外3期临床试验

flu, disease, Pharmaceutical

Posts navigation